Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
36 hedge funds and large institutions have $628M invested in Myovant Sciences Ltd. in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
6% more funds holding
Funds holding: 34 → 36 (+2)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
17% less capital invested
Capital invested by funds: $756M → $628M (-$129M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$1.34M |
| 2 |
SCM
Sio Capital Management
New York
|
+$980K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$623K |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$402K |
| 5 |
State Street
Boston,
Massachusetts
|
+$226K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$6.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.25M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.03M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$905K |
| 5 |
Millennium Management
New York
|
-$411K |
MYOV Hedge Fund Activity: Q4 2017 in Review
36 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q4 2017, worth a combined $628M — down 17% from $756M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MYOV positions and 6 closed out — a net gain of 2 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Ardsley Advisory Partners, opening a new position worth an estimated $1.34M. The largest seller was Deerfield Management, exiting entirely with an estimated $6.2M sold.
- 36 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q4 2017, up from 34 in Q3 2017.
- Funds reported $628M of Myovant Sciences Ltd. stock for Q4 2017, down 17% quarter-over-quarter.
- 8 funds opened new Myovant Sciences Ltd. positions in Q4 2017 and 6 closed out, a net change of +2 holders.
- The largest Myovant Sciences Ltd. buyer in Q4 2017 was Ardsley Advisory Partners, an estimated $1.34M added.
- The largest Myovant Sciences Ltd. seller in Q4 2017 was Deerfield Management, an estimated $6.2M sold.
Based on aggregated 13F filings for Q4 2017.